Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

SELL
$43.0 - $65.64 $783,976 - $1.2 Million
-18,232 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$38.74 - $62.09 $706,307 - $1.13 Million
18,232 New
18,232 $1.12 Million

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.05B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Virtue Capital Management, LLC Portfolio

Follow Virtue Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtue Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtue Capital Management, LLC with notifications on news.